Ingenia Therapeutics is a biotechnology company developing a therapeutic antibody candidate for capillary diseases.
Ingenia Therapeutics has raised $5.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in June 2024.
Ingenia Therapeutics is headquartered in Watertown, United States.
Ingenia Therapeutics is a biotechnology company developing a therapeutic antibody candidate for capillary diseases.
Ingenia Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Ingenia Therapeutics — Funding & Investors." VCBacked, June 21, 2024, https://www.vcbacked.co/company/ingenia-therapeutics. Accessed August 14, 2026.
VCBacked. (2024). Ingenia Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/ingenia-therapeutics
{{cite web |title=Ingenia Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/ingenia-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated